Table 1.
The routine immunization schedule recommended in the UK during the study period
| Vaccine | Trade name and manufacturer | Recommended age at vaccination (months) |
|---|---|---|
| DTaP3-IPV-Hib | Infanrix-IPV-Hib, GSK | 2, 3, 4 |
| Meningococcal serogroup B | Bexsero, GSK | 2, 4, 12 |
| 13-valent pneumococcal conjugate | Prevenar13, Pfizer | 2, 4, 12 |
| Oral live attenuated rotavirus | Rotarix, GSK | 2, 3 |
| Meningococcal serogroup C conjugate | NeisVac-C, GSK | 3 |
| Hib-MenC | Menitorix, GSK | 12 |
| Measles-mumps-rubella (MMR) | Priorix, Sanofi Pasteur | 12 |
Abbreviations: DTaP3-IPV diphtheria, tetanus, acellular pertussis (three pertussis antigens, 25 μg each of pertussis toxoid and filamentous haemagglutinin and 8 μg of pertactin), inactivated poliovirus, Haemophilus influenzae type B, IPV inactivated poliovirus, Hib Haemophilus influenzae type b, MenC meningococcal serogroup C, GSK GlaxoSmithKleine